Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000950170-24-062982

Chief Executive Officer sold 3,075 shares at $0.75 ($2,304)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-17 Sale : show line 1 in the form −3,075 $0.75 $2,304 789,620 D
Open-market sales · 3,075 sh · avg $0.75 · $2,304
Loading xslF345X05/ownership.xml…